SEARCH

SEARCH BY CITATION

LITERATURE CITED

  • 1
    KwonBS,WeissmanSM. cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci USA 1989; 86: 19631967.
  • 2
    WattsTH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005; 23: 2368.
  • 3
    WenT,BukczynskiJ,WattsTH. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J Immunol 2002; 168: 48974906.
  • 4
    LeeHW,ParkSJ,ChoiBK,KimHH,NamKO,KwonBS. 4-1BB promotes the survival of CD8+ T lymphocytes by increasing expression of Bcl-xL and Bfl-1. J Immunol 2002; 169: 48824888.
  • 5
    HalsteadES,MuellerYM,AltmanJD,KatsikisPD. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol 2002; 3: 536541.
  • 6
    DawickiW,WattsTH. Expression and function of 4-1BB during CD4 versus CD8 T cell responses in vivo. Eur J Immunol 2004; 34: 743751.
  • 7
    WolflM,KuballJ,HoWY,NguyenH,ManleyTJ,BleakleyM,GreenbergPD. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007; 110: 201210.
  • 8
    HoWY,BlattmanJN,DossettML,YeeC,GreenbergPD. Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction. Cancer Cell 2003; 3: 431437.
  • 9
    MainoVC,PickerLJ. Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 1998; 34: 207215.
  • 10
    MainoVC,MaeckerHT. Cytokine flow cytometry: A multiparametric approach for assessing cellular immune responses to viral antigens. Clin Immunol 2004; 110: 222231.
  • 11
    BettsMR,BrenchleyJM,PriceDA,De RosaSC,DouekDC,RoedererM,KoupRA. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003; 281: 6578.
  • 12
    HoWY,NguyenHN,WolflM,KuballJ,GreenbergPD. In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire. J Immunol Methods 2006; 310: 4052.
  • 13
    MehrotraS,StevensR,ZengouR,ChakrabortyNG,ButterfieldLH,EconomouJS,DorskyDI,MukherjiB. Regulation of melanoma epitope-specific cytolytic T lymphocyte response by immature and activated dendritic cells, in vitro. Cancer Res 2003; 63: 56075614.
  • 14
    ChattopadhyayPK,PriceDA,HarperTF,BettsMR,YuJ,GostickE,PerfettoSP,GoepfertP,KoupRA,De RosaSC,BruchezMP,RoedererM. Quantum dot semiconductor nanocrystals for immunophenotyping by polychromatic flow cytometry. Nat Med 2006; 12: 972977.
  • 15
    KwonBS,TanKB,NiJ,OhKO,LeeZH,KimKK,KimYJ,WangS,GentzR,YuGL,HarropJ,LynSD,SilvermanC,PorterTG,TrunehA,YoungPR. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J Biol Chem 1997; 272: 1427214276.
  • 16
    HuralJ,HortonH,HuangY,McElrathMJ,De RosaSC. Validation of intracellular cytokine staining assays for evaluation of t cell responses in vaccine trials. 2008; Presented at the third MASIR conference, La Plagne, France. 73A: in press, this issue.
  • 17
    NomuraL,MainoVC,MaeckerHT. Standardization and optimization of multiparameter flow cytometric studies. Cytometry A 2008; 73A: in press, Doi: 10.1002/cyto.a.20602, this issue.
  • 18
    WehlerTC,NonnM,BrandtB,BrittenCM,GroneM,TodorovaM,LinkI,KhanSA,MeyerRG,HuberC,HartwigUF,HerrW. Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines. Blood 2007; 109: 365373.
  • 19
    AriyaratanaS,LoebDM. The role of the Wilms tumour gene (WT1) in normal and malignant haematopoiesis. Expert Rev Mol Med 2007; 9: 117.
  • 20
    KernF,SurelIP,BrockC,FreistedtB,RadtkeH,ScheffoldA,BlasczykR,ReinkeP,Schneider-MergenerJ,RadbruchA,WaldenP,VolkHD. T-cell epitope mapping by flow cytometry. Nat Med 1998; 4: 975978.
  • 21
    BundeT,KirchnerA,HoffmeisterB,HabedankD,HetzerR,CherepnevG,ProeschS,ReinkeP,VolkHD,LehmkuhlH,KernF. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005; 201: 10311036.
  • 22
    MielkeS,SolomonSR,BarrettAJ. Selective depletion strategies in allogeneic stem cell transplantation. Cytotherapy 2005; 7: 109115.
  • 23
    AmroliaPJ,Muccioli-CasadeiG,YvonE,HulsH,SiliU,WiederED,BollardC,MichalekJ,GhetieV,HeslopHE,MolldremJJ,RooneyCM,SchlinderJ,VitettaE,BrennerMK. Selective depletion of donor alloreactive T cells without loss of antiviral or antileukemic responses. Blood 2003; 102: 22922299.
  • 24
    AmroliaPJ,Muccioli-CasadeiG,HulsH,AdamsS,DurettA,GeeA,YvonE,WeissH,CobboldM,GasparHB,RooneyC,KuehnleI,GhetieV,SchindlerJ,KranceR,HeslopHE,VeysP,VitettaE,BrennerMK. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006; 108: 17971808.
  • 25
    HartwigUF,NonnM,KhanS,MeyerRG,HuberC,HerrW. Depletion of alloreactive T cells via CD69: Implications on antiviral, antileukemic and immunoregulatory T lymphocytes. Bone Marrow Transplant 2006; 37: 297305.
  • 26
    HartwigUF,NonnM,KhanS,LinkI,HuberC,HerrW. Depletion of alloreactive donor T lymphocytes by CD95-mediated activation-induced cell death retains antileukemic, antiviral, and immunoregulatory T cell immunity. Biol Blood Marrow Transplant 2008; 14: 99109.
  • 27
    AssenmacherM. Cytokine capture system (CCS) for enrichment of T cells for adoptive transfer. 2008; 73A: Presented at the third MASIR conference, La Plagne, France.
  • 28
    BlazarBR,KwonBS,Panoskaltsis-MortariA,KwakKB,PeschonJJ,TaylorPA. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J Immunol 2001; 166: 31743183.
  • 29
    BlazarBR,LeesCJ,MartinPJ,NoelleRJ,KwonB,MurphyW,TaylorPA. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions. J Immunol 2000; 165: 49014909.
  • 30
    BeetzS,MarischenL,KabelitzD,WeschD. Human gamma delta T cells: Candidates for the development of immunotherapeutic strategies. Immunol Res 2007; 37: 97111.
  • 31
    O'ReillyRJ,DoubrovinaE,TrivediD,HasanA,KollenW,KoehneG. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants. Immunol Res 2007; 38: 237250.
  • 32
    RosenbergSA,RestifoNP,YangJC,MorganRA,DudleyME. Adoptive cell transfer: A clinical path to effective cancer immunotherapy. Nat Rev Cancer 2008; 8: 299308.